ACAD logo

ACADIA Pharmaceuticals (ACAD) Working capital

annual working capital:

$543.45M+$181.58M(+50.18%)
December 31, 2024

Summary

  • As of today (May 18, 2025), ACAD annual working capital is $543.45 million, with the most recent change of +$181.58 million (+50.18%) on December 31, 2024.
  • During the last 3 years, ACAD annual working capital has risen by +$21.69 million (+4.16%).
  • ACAD annual working capital is now -20.71% below its all-time high of $685.42 million, reached on December 31, 2019.

Performance

ACAD Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADbalance sheet metrics

quarterly working capital:

$568.41M+$24.96M(+4.59%)
March 31, 2025

Summary

  • As of today (May 18, 2025), ACAD quarterly working capital is $568.41 million, with the most recent change of +$24.96 million (+4.59%) on March 31, 2025.
  • Over the past year, ACAD quarterly working capital has increased by +$223.71 million (+64.90%).
  • ACAD quarterly working capital is now -17.07% below its all-time high of $685.42 million, reached on December 31, 2019.

Performance

ACAD quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

ACAD Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+50.2%+64.9%
3 y3 years+4.2%+34.5%
5 y5 years-20.7%-9.0%

ACAD Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+50.2%at high+104.1%
5 y5-year-20.7%+50.2%-12.5%+104.1%
alltimeall time-20.7%+7556.8%-17.1%+4190.3%

ACAD Working capital History

DateAnnualQuarterly
Mar 2025
-
$568.41M(+4.6%)
Dec 2024
$543.45M(+50.2%)
$543.45M(+22.3%)
Sep 2024
-
$444.34M(+13.6%)
Jun 2024
-
$391.06M(+13.5%)
Mar 2024
-
$344.70M(-4.7%)
Dec 2023
$361.87M(-5.3%)
$361.87M(+25.0%)
Sep 2023
-
$289.57M(-5.0%)
Jun 2023
-
$304.69M(+9.4%)
Mar 2023
-
$278.55M(-27.1%)
Dec 2022
$382.31M(-26.7%)
$382.31M(-5.6%)
Sep 2022
-
$404.98M(-2.4%)
Jun 2022
-
$414.84M(-1.8%)
Mar 2022
-
$422.62M(-19.0%)
Dec 2021
$521.75M(-14.7%)
$521.75M(-5.6%)
Sep 2021
-
$552.70M(+0.4%)
Jun 2021
-
$550.40M(-2.5%)
Mar 2021
-
$564.61M(-7.7%)
Dec 2020
$611.65M(-10.8%)
$611.65M(-4.2%)
Sep 2020
-
$638.36M(-1.7%)
Jun 2020
-
$649.31M(+3.9%)
Mar 2020
-
$624.68M(-8.9%)
Dec 2019
$685.42M(+46.9%)
$685.42M(+1.6%)
Sep 2019
-
$674.59M(+80.8%)
Jun 2019
-
$373.13M(-7.0%)
Mar 2019
-
$401.42M(-14.0%)
Dec 2018
$466.54M(+43.8%)
$466.54M(+119.7%)
Sep 2018
-
$212.31M(-15.7%)
Jun 2018
-
$251.88M(-14.3%)
Mar 2018
-
$293.93M(-9.4%)
Dec 2017
$324.45M(-35.8%)
$324.45M(-11.3%)
Sep 2017
-
$365.83M(-9.2%)
Jun 2017
-
$402.83M(-9.4%)
Mar 2017
-
$444.49M(-12.0%)
Dec 2016
$505.31M(+156.4%)
$505.31M(-10.5%)
Sep 2016
-
$564.34M(+42.9%)
Jun 2016
-
$394.88M(-10.5%)
Mar 2016
-
$441.23M(+123.9%)
Dec 2015
$197.09M(-36.2%)
$197.09M(-12.4%)
Sep 2015
-
$225.11M(-11.4%)
Jun 2015
-
$254.01M(-10.3%)
Mar 2015
-
$283.25M(-8.3%)
Dec 2014
$308.78M
$308.78M(-6.4%)
Sep 2014
-
$329.81M(-5.6%)
DateAnnualQuarterly
Jun 2014
-
$349.51M(-4.2%)
Mar 2014
-
$364.79M(+101.1%)
Dec 2013
$181.38M(+76.8%)
$181.38M(-4.9%)
Sep 2013
-
$190.81M(-4.1%)
Jun 2013
-
$198.99M(+104.5%)
Mar 2013
-
$97.29M(-5.2%)
Dec 2012
$102.60M(+297.9%)
$102.60M(+483.0%)
Sep 2012
-
$17.60M(+17.2%)
Jun 2012
-
$15.02M(-24.8%)
Mar 2012
-
$19.95M(-22.6%)
Dec 2011
$25.78M(-19.1%)
$25.78M(-15.1%)
Sep 2011
-
$30.35M(-13.4%)
Jun 2011
-
$35.07M(-13.2%)
Mar 2011
-
$40.41M(+26.7%)
Dec 2010
$31.89M(-5.6%)
$31.89M(+46.1%)
Sep 2010
-
$21.82M(-13.9%)
Jun 2010
-
$25.33M(-11.8%)
Mar 2010
-
$28.72M(-15.0%)
Dec 2009
$33.77M(-34.2%)
$33.77M(-18.7%)
Sep 2009
-
$41.56M(-12.1%)
Jun 2009
-
$47.28M(+28.3%)
Mar 2009
-
$36.85M(-28.2%)
Dec 2008
$51.33M(-54.2%)
$51.33M(-20.2%)
Sep 2008
-
$64.33M(-18.8%)
Jun 2008
-
$79.22M(-18.1%)
Mar 2008
-
$96.70M(-13.6%)
Dec 2007
$111.97M(+71.6%)
$111.97M(-12.4%)
Sep 2007
-
$127.80M(-10.4%)
Jun 2007
-
$142.57M(+158.8%)
Mar 2007
-
$55.09M(-15.6%)
Dec 2006
$65.25M(+69.8%)
$65.25M(-15.3%)
Sep 2006
-
$77.04M(-11.8%)
Jun 2006
-
$87.36M(+121.8%)
Mar 2006
-
$39.38M(+2.5%)
Dec 2005
$38.42M(+31.7%)
$38.42M(-20.5%)
Sep 2005
-
$48.31M(-19.9%)
Jun 2005
-
$60.32M(+88.7%)
Mar 2005
-
$31.96M(+9.5%)
Dec 2004
$29.18M(+45.5%)
$29.18M(-17.9%)
Sep 2004
-
$35.54M(-12.7%)
Jun 2004
-
$40.69M(+207.1%)
Mar 2004
-
$13.25M(-33.9%)
Dec 2003
$20.05M(+182.4%)
$20.05M
Dec 2002
$7.10M
-

FAQ

  • What is ACADIA Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual working capital year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly working capital year-on-year change?

What is ACADIA Pharmaceuticals annual working capital?

The current annual working capital of ACAD is $543.45M

What is the all time high annual working capital for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual working capital is $685.42M

What is ACADIA Pharmaceuticals annual working capital year-on-year change?

Over the past year, ACAD annual working capital has changed by +$181.58M (+50.18%)

What is ACADIA Pharmaceuticals quarterly working capital?

The current quarterly working capital of ACAD is $568.41M

What is the all time high quarterly working capital for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly working capital is $685.42M

What is ACADIA Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, ACAD quarterly working capital has changed by +$223.71M (+64.90%)
On this page